Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer

Lung Cancer

Volumn 64, Issue 1, 2009, Pages 92-97

  Paci, Massimiliano ^a   Maramotti, Sally ^a   Bellesia, Enrica ^a   Formisano, Debora ^a   Albertazzi, Laura ^a   Ricchetti, Tommaso ^a   Ferrari, Guglielmo ^a   Annessi, Valerio ^a   Lasagni, Daniela ^a   Carbonelli, Cristiano ^a   De Franco, Salvatore ^a   Brini, Maria ^a   Sgarbi, Giorgio ^a   Lodi, Renzo ^b  

^a S MARIA NUOVA HOSPITAL   (Italy)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Biomarker; Circulating free DNA; Early diagnosis; Lung cancer; PCR; Prognosis

Indexed keywords

BIOLOGICAL MARKER; CIRCULATING PLASMA DNA; DNA; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; GENE; HTERT GENE; HUMAN; HUMAN TISSUE; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ASSAY; RISK FACTOR; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; CASE-CONTROL STUDIES; DNA, NEOPLASM; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASTIC CELLS, CIRCULATING; POLYMERASE CHAIN REACTION; PROGNOSIS; ROC CURVE; SENSITIVITY AND SPECIFICITY; TELOMERASE; TUMOR MARKERS, BIOLOGICAL;

EID: 61449150588     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2008.07.012     Document Type: Article

References (34)

1. Alberg A.J., and Samet J.M. Epidemiology of lung cancer. Chest 123 1 Suppl. (2003) S21-S49
2. Sethi T. Lung cancer. Introduction. Thorax 57 (2002) 992-993
3. Sozzi G., Oggioni M., Alasio L., Conte D., Tavecchio L., Pilotti S., et al. Molecular changes track recurrence and progression of bronchial precancerous lesions. Lung Cancer 37 (2002) 267-270
4. Huber R.M., and Stratakis D.F. Molecular oncology-perspectives in lung cancer. Lung Cancer 45 (2004) S209-S213
5. Sozzi G. Molecular biology of lung cancer. Eur J Cancer 37 (2001) 63-73
6. Sozzi G., Conte D., Leon M.E., Ciricione R., Roz L., Ratcliffe C., et al. Quantification of free circulating DNA as a diagnostic marker in lung cancer. J Clin Oncol 21 (2003) 3902-3908
7. Sozzi G., Conte D., Mariani L., Lo Vullo S., Roz L., Lombardo C., et al. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients. Cancer Research 61 (2001) 4675-4678
8. Mandel P., and Mètais P. Les acides nuclèiques du plasma sanguin chez l'homme. CR Acad Sci Paris 142 (1948) 241-243
9. Leon S.A., Shapiro B., Sklaroff D.M., and Yaros M.J. Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37 (1977) 646-650
10. Chen X.Q., Stroun M., Magnenat J.L., Nicod L.P., Kurt A.M., Lyautey J., et al. Microsatellite alterations in plasma DNA of small cell lung cancer patients. Nat Med 2 (1996) 1033-1035
11. Nawroz H., Koch W., Anker P., Stroun M., and Sidransky D. Microsatellite alterations in serum DNA of head and neck cancer patients. Nat Med 2 (1996) 1035-1037
12. Sozzi G., Musso K., Ratcliffe C., Goldstraw P., Pierotti M.A., and Pastorino U. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis. Clin Cancer Res 5 (1999) 2689-2692
13. Stroun M., Anker P., Lyautey J., Lederrey C., and Maurice P.A. Isolation and characterization of DNA from the plasma of cancer patients. Eur J Cancer Clin Oncol 23 (1987) 707-712
14. Garcia-Olmo D., and Garcia-Olmo D.C. Functionality of circulating DNA. The hypotesis of genometastases. Ann N Y Acad Sci 945 (2001) 265-275
15. Johnson P.J., and Lo D.Y.M. Plasma nucleic acids in diagnosis and management of malignant disease. Clin Chem 48 (2002) 1186-1193
16. Stroun M., Lyautey J., Lederrey C., Olson-Sand A., and Anker P. About the possible origin and mechanism of circulating DNA apoptosis and active DNA release. Clin Chim Acta 313 (2001) 139-142
17. Pathak A.K., Butani M., Kumar S., Mohan A., and Guleria R. Circulating free DNA in plasma/serum of lung cancer patients as a potential screening and prognostic tool. Clin Chem 52 (2006) 1833-1842
18. Bunn Jr. P.J. Early detection of lung cancer using serum RNA or DNA markers: ready for "prime time" or for validation?. Clin Oncol 21 (2003) 3891-3893
19. Ziegler A., Zangemeister-Wittke U., and Stahel R.A. Circulating DNA a new diagnostic gold mine?. Cancer Treat Rev 28 (2002) 255-271
20. Galeazzi M., Morozzi G., Piccini M., Chen J., Bellisai F., Fineschi S., et al. Dosage and characterization in systemic autoimmune disorders. Autoimmun Rev 2 (2003) 50-55
21. Lippmann M.L., Morgan L., Fein A., Shapiro B., and Leon S.A. Plasma and serum concentrations of DNA in pulmonary thromboembolism. Am Rev Respir Dis 125 4 (1982) 416-419
22. Laktionov P.P., Tamkovich S.N., Rykova E.Y., Bryzgunova O.E., Starikov A.V., Kuznetsova N.P., et al. Extracellular circulating nucleic acids in human plasma in health and disease. Nucleosides Nucleotides Nucleic Acids 23 (2004) 879-883
23. Antonatos D., Patsilinakos S., Spanodimos S., Korkonikitas P., and Tsigas D. Cell-free DNA levels as a prognostic marker in acute myocardial infarction. Ann N Y Acad Sci 1075 (2006) 278-281
24. Davis L., and Davis J.S. Detection of circulating DNA by counterimmunoelectrophoresis (CIE). Arthritis Rheum 16 (1973) 58-68
25. Gormally E., Caboux E., Vineis P., and Hainaut P. Circulating free DNA in plasma or serum as biomarker of carcinogenesis: practical aspects and biological significance. Mutat Res 635 (2007) 105-117
26. Gautschi O., Bigosch C., Huegli B., Jermann M., Marx A., Chassè E., et al. Circulating deoxyribonucleic acid as a prognostic marker in non-small cell lung cancer patients undergoing chemotherapy. J Clin Oncol 22 (2004) 4157-4164
27. Herrera L.J., Raja S., Gooding W.E., El-Hefnawy T., Kelly L., Luketich J.D., et al. Quantitative analysis of circulating plasma DNA as a tumor marker in thoracic malignancies. Clin Chem 51 (2005) 113-118
28. Gal S., Fidler C., Lo Y.M., Taylor M., Han C., Moore J., et al. Quantification of circulating DNA in the serum of breast cancer patients by Real-Time PCR. Br J Cancer 90 (2004) 1211-1220
29. Sai S., Ichikawa D., Tomita H., Ikoma H., Kikuchi S., Fujiwara H., et al. Quantification of plasma cell-free DNA in patients with gastric cancer. Anticancer Res 27 4C (2007) 2747-2751
30. Boni L., Cassinotti E., Canziani M., Dionigi G., Rovera F., and Dionigi R. Free circulating DNA as possibile tumour marker in colorectal cancer. Surg Oncol 16 1 Suppl (2007) S29-S31
31. Zanetti-Dallenbach R., Wight E., Fan A.X., Lapaire O., Hahn S., Holzgreve W., et al. Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease. Anticancer Res 28 2A (2008) 921-925
32. Altimari A., Grigioni A.D., Benedettini E., Gabusi E., Schiavina R., Martinelli A., et al. Diagnostic role of circulating free plasma DNA detection in patients with localized prostate cancer. Am J Clin Pathol 129 5 (2008) 756-762
33. Camps C., Sirera R., Bremnes R.M., Ròdenas V., Blasco A., Safont M.J., et al. Quantification in the serum of the catalytic fraction of reverse telomerase: a useful prognostic factor in advanced non-small cell lung cancer. Anticancer Res 26 (2007) 4905-4910
34. Frattini M., Balestra D., Verderio P., Gallino G., Leo E., Sozzi G., et al. Reproducibility of a semiquantitative measurement of circulating DNA in plasma from neoplastic patients. J Clint Oncol 23 13 (2005) 3163-3164